Federal legislation can be advanced or delayed by a variety of means. The hemp plant is a natural alternative to synthetic chemicals. The U.S. Congress has stalled. Competing proposals have failed to gain House floor votes. As stakeholders continue to monitor federally-scheduled recriminalization, these legislative roadblocks have significant consequences for the industrial cannabis sector and other businesses.
Hemp: Federal Legislative Barriers to Hemp
House votes on competing amendments to the Constitution aimed at delaying or speeding up federal criminalization of hemp THC will not be held this week. In a recent report, Marijuana MomentOne amendment was removed, and the other blocked by the House Rules Committee. The lack of legislative action leaves operators and investors on the industrial hemp industry in an uncertain state regarding the future of the regulatory status for hemp-derived cannabinoids.
Discussions surrounding the issues of these The hemp plant is a natural alternative to synthetic chemicals. This highlights the ongoing tensions in federal regulations and the market expansion for hemp-derived goods. Potential recriminalization may have significant impacts on the formulation of products, their distribution, or consumer access. Therefore, industry professionals and legal professionals should closely monitor this potential.
Medical Cannabis Policy Changes at the State Level
Maryland Medical Cannabis Workplace Protections
Maryland Governor Wes Moore signed legislation to protect firefighter and rescue workers from punishment if they use medical cannabis while off-duty. It reflects the growing tendency among states to reconcile employment policies with medical cannabis usage, especially for vital service personnel.
North Carolina Considers Medical-Cannabis Legislation
North Carolina also has a renewed interest in medical marijuana legislation. Senate Pro Tempore Phil Berger, a Republican senator from North Carolina, said that his members would be discussing advancing medical cannabis legislation. Hemp Gazette previously reported on the federal marijuana rescheduling effort. Potential shifts in federal classification may provide an extra push for states, like North Carolina, to implement regulated medical marijuana programs.
Nebraska Officials discuss federal scheduling
State officials continue to discuss the implications of federal marijuana redistribution. Nebraska Governor Jim Pillen and U.S. Senator Pete Ricketts, R-NE, avoided most direct questions about how the federal rescheduling could impact Nebraska. Rep. Don Bacon, R-NE, publicly said, “I fully support the move of the administration.” This shows a difference in views on the federal cannabis policies.
Other state regulatory actions
- Oklahoma’s judge has lifted a ban on the operations of a cannabis medical business. It can now resume.
- Colorado regulators have published guidance addressing specific cryptocurrency ATM scams which targeted cannabis businesses. This highlights the ongoing financial challenges for this industry.
- New York regulators actively pursue enforcement actions against marijuana businesses that are not licensed, with the goal of stabilizing the market.
- Arkansas regulators published a directory for hemp consumable products to increase transparency and improve the experience of consumers.
- Vermont regulators have published a booklet detailing Vermont’s Medical Cannabis Program, which provides essential information to patients and prescribing physicians.
Industry and Business Developments
Cannabis Beverage Product Validation
A piece of writing published by Marijuana MomentLeah Kollross, of 23rd State raised concern about the cannabis beverages sector. Kollross claimed that cannabis beverage manufacturers “cannot justify their claims”, due to the lack of independent validation. The critique highlights the need for robust scientific evidence, quality assurance and product attributes to build consumer trust in the rapidly growing cannabis derivatives industry.
Public Listing and Corporate Finance
A federal bill that would allow marijuana companies to be listed on stock exchanges has gained a new sponsor, making it two. The incremental progress is a reflection of ongoing efforts to improve financial access to cannabis businesses, who currently face major obstacles due to the federal prohibition. According to Marijuana Moment’s report on corporate finance, Rubicon Organics Inc. signed an agreement temporarily increasing its line of credits, which signals strategic financial maneuvering in the publicly-traded cannabis sector.
Cannabis Cultivation in Historical Perspective
New archaeological research has revealed the historical context of cannabis cultivation. It reveals that cannabis was a major crop in Northern China by the Late Neolithic. This study shows that the processing of cannabis and its consumption was “deeply embedded” in everyday life, making it an indispensable part of agricultural subsistence. The research shows that cannabis has been an important agricultural product for centuries, even before its industrial and medical uses.
Disclaimer: This article contains only general information and is not intended to be a medical recommendation. Hemp Gazette is not a medical provider and does not offer diagnoses or treatment plans. Before making decisions about your health, or a medical condition in general, always consult with a trained healthcare provider. Therapeutic Goods Administration of Australia has not evaluated statements about the therapeutic benefits of cannabinoid products, hemp or cannabis. TGA regulations allow Australians to access medical cannabis through prescription.